E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/10/2011 in the Prospect News Structured Products Daily.

JPMorgan plans 6.6%-8.6% trigger yield notes linked to Pfizer

By Jennifer Chiou

New York, Aug. 10 - JPMorgan Chase & Co. plans to price 6.6% to 8.6% trigger yield optimization notes due Aug. 17, 2012 linked to the common stock of Pfizer Inc., according to an FWP with the Securities and Exchange Commission.

The face amount of each note will be equal to the initial share price of Pfizer stock.

Interest will be payable monthly.

The payout at maturity will be par in cash unless the final price of Pfizer stock is less than 75% of the initial share price, in which case investors will receive one Pfizer share per note.

The notes (Cusip: 46636T887) are expected to price on Aug. 12 and settle on Aug. 17.

UBS Financial Services Inc. and J.P. Morgan Securities LLC are the agents.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.